Gertrude Elion

 

Gertrude Elion

“Don’t be afraid of hard work. Nothing worthwhile comes easily. Don’t let others discourage you or tell you that you can’t do it. In my day I was told women didn’t go into chemistry. I saw no reason why we couldn’t.”Gertrude B. Elion

American pharmacologist and biochemist, Gertrude B. Elion is famous for her scientific discovery of drugs to treat leukemia and herpes and to prevent the rejection of kidney transplants. This discovery earned her Nobel Prize in Physiology or Medicine in 1988 which she shared with George H. Hitchings, her long-time boss and collaborator at Burroughs-Wellcome, and also Sir James W. Black. After receiving the Nobel Prize she once said:

“People ask me often (was) the Nobel Prize the thing you were aiming for all your life? And I say that would be crazy. Nobody would aim for a Nobel Prize because, if you didn’t get it, your whole life would be wasted. What we were aiming at was getting people well, and the satisfaction of that is much greater than any prize you can get.”

She is holder of 45 patents, 23 honorary degrees, and a lengthy list of other honors. She was unmarried.

Early Life, Education and Career:

Gertrude Elion was born in New York City on January 23, 1918 to immigrant parents. She completed her graduation from Hunter College with a B.A. degree in chemistry in 1937. During this time she also planned to become a cancer researcher but for several years worked as a lab assistant, food analyst (tested pickles and berries for quality at the Quaker Maid Company), and high school teacher while studying for her Masters degree at night. She completed her M.S. in chemistry from New York University in 1941.

When World War II broke out, there was an urgent need for women at scientific laboratories so she left to work as an assistant to George H. Hitchings at the Burroughs-Wellcome pharmaceutical company (now GlaxoSmithKline). She never obtained a formal Ph.D., but was later awarded an honorary Ph.D from Polytechnic University of New York in 1989 and honorary SD degree from Harvard University in 1998.

While working with H. Hitchings, Elion helped develop the first drugs to combat leukemia, herpes, and AIDS, and established new research methods to produce drugs that could target specific pathogens. The medicines she developed include acyclovir (for herpes), allopurinol (for gout), azathioprine (which limits rejection in organ transplants), purinethol (for leukemia), pyrimethamine (for malaria), and trimethoprim (for meningitis and bacterial infections).

During 1967 she occupied the position of the head of the company’s Department of Experimental Therapy and officially retired in 1983. Despite her retirement, Elion continued working almost full time at the lab, and oversaw the adaptation of azidothymidine (AZT), which became the first drug used for treatment of AIDS.

Death:

Gertrude Elion died in North Carolina on February 21, 1999. She was always admired by a number of students and colleagues for her brilliancy and dedication to science.